REFERENCE
WHO.Everolimus and serious gastrointestinal disorders. WHO Pharmaceuticals Newsletter: 13-16, No. 3, 1 Jun 2012. Available from: URL: http://www.who.int/medicines/publications/Newsletter%5f3%5f2012.pdf
Rights and permissions
About this article
Cite this article
WHO publishes report on serious GI events with everolimus. React. Wkly. 1410, 1 (2012). https://doi.org/10.2165/00128415-201214100-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214100-00001